Sutro Biopharma (STRO) Current Taxes (2023 - 2024)
Sutro Biopharma (STRO) reported Current Taxes of $18000.0 for Q4 2024, down 99.88% on a YoY basis from $15.2 million in Q1 2024, and little changed sequentially from $18000.0 in Q3 2024.
Sutro Biopharma (STRO) Current Taxes (2023 - 2024) Analysis & Trends
Sutro Biopharma (STRO) has 2 years of Current Taxes data on file, last reported at $18000.0 in Q4 2024.
- For the quarter ending Q4 2024, Current Taxes fell 99.88% year-over-year to $18000.0; the trailing twelve-month figure through Dec 2024 stood at $18000.0 (down 99.88% YoY), and the FY2024 full-year result was $18000.0, down 99.88% from the prior year.
- Current Taxes was little changed at $18000.0 in Q4 2024, from $18000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $15.2 million in Q4 2023 to a low of $11000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 15.17 Mn |
| Dec 31, 2023 | 15.17 Mn |